| RENO, Nev., Dec. 22, 2011 /PRNewswire/ -- Lifeline Biotechnologies, Inc. , (OTC Market: LLBO) announces a new engineering contract with Synergy Technology, Inc. to focus on device value engineering. Jim Holmes, CEO, says, "This relationship will result in an updated design for our breast testing device package for a current, more cost effective technology while maintaining the product integrity from our previous clinical trials. We expect this will reduce the selling price sign...continued LLBO |
Thursday, December 22, 2011
Lifeline Biotechnologies' First Warning Retains Engineering Firm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment